Hence, in this study, the ability of salinomycin to enhance the cytotoxicity of doxorubicin in HCC cells was assessed, along with the underlying mechanisms focusing on EMT and FOXO3a. The gene discussed is FOXO3; the disease is hepatocellular carcinoma.